Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Droit

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Faculty Reviews|March 4, 2021
Recent advances in understanding osteosarcoma and emerging therapiesNathalie Gaspar, Maria Eugenia Marques da Costa, Olivia Fromigue, et al.
Genome Biology|May 13, 2026
scArchon: a scalable benchmarking framework for assessing single-cell perturbation modelsJean Radig, Robin Droit, Daria Doncevic, et al.
European Journal of Medical Genetics|April 27, 2024
From biology to personalized medicine: Recent knowledge in osteosarcomaAudrey Mohr, Maria Eugenia Marques Da Costa, Olivia Fromigue, et al.
Frontiers in Oncology|June 28, 2023
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft modelsMaria Eugenia Marques da Costa, Robin Droit, Pierre Khneisser, et al.
Cancer Research|January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at DiagnosisAntonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Faculty Reviews|March 4, 2021
Recent advances in understanding osteosarcoma and emerging therapiesNathalie Gaspar, Maria Eugenia Marques da Costa, Olivia Fromigue, et al.
Genome Biology|May 13, 2026
scArchon: a scalable benchmarking framework for assessing single-cell perturbation modelsJean Radig, Robin Droit, Daria Doncevic, et al.
European Journal of Medical Genetics|April 27, 2024
From biology to personalized medicine: Recent knowledge in osteosarcomaAudrey Mohr, Maria Eugenia Marques Da Costa, Olivia Fromigue, et al.
Frontiers in Oncology|June 28, 2023
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft modelsMaria Eugenia Marques da Costa, Robin Droit, Pierre Khneisser, et al.
Cancer Research|January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at DiagnosisAntonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
Pageof 1